While outbreaks of highly pathogenic avian influenza viruses (HPAIV) in Europe used to be rare and geographically contained, the situation has dramatically changed in the last few years with thousands of outbreaks reported in domestic poultry and wild birds. Despite being an intensive field of research, many unknowns remain as we are still struggling to predict HPAIV emergence, avoid viral spread and limit the socio-economic impact entailed predominantly by control measures. Vaccination of domestic poultry against avian influenza, is now being given full consideration, as it is becoming clear that traditional prevention and control approaches alone will not curb the accelerating pace of occurrence of devastating HPAIV epidemics. On 1 October 2023, France became the first EU country to implement a nation-wide vaccination campaign in ducks. However, vaccinating domestic poultry does not come without important challenges. VIVACE therefore aims at putting together a doctoral network to contribute to fully integrate poultry vaccination approaches into efficient management strategies for HPAIV. We will do so by unravelling the impact current and upcoming EU vaccination policies will have on avian influenza virus evolution, surveillance and control strategies and societal burden of HPAI. This will be done through a combination of disciplines from life sciences, epidemiology, computer sciences and social and behavioural sciences. The training program proposed here includes scientific and transferrable skill sessions, builds on the integrated added values of complementing expertise (virology, immunology, modelling, spatial and molecular epidemiology, social psychology, economics and policy), and full access to state-of-the-art technologies in excellent environments. The consortium gathers 15 universities or research institutes and 5 private companies, securing both inter-sectoriality and wide geographic distribution with tailored epidemiological and vaccination contexts.

HARIA re-defines the nature of physical human-robot interaction (HRI), laying the foundations of a new research field, i.e., human sensorimotor augmentation, whose constitutive elements are: i) AI-powered wearable and grounded supernumerary robotic limbs and wearable sensorimotor interfaces; ii) methods for augmentation enabling users to directly control and feel the extra limbs exploiting the redundancy of the human sensorimotor system through wearable interfaces; iii) clear target populations, i.e., chronic stroke and spinal cord injured individuals, and real-world application scenarios to demonstrate the extraordinary value of the paradigm shift that HARIA represents in HRI and the great impact on the motivation to re-use the paretic arm(s), with consequent improvement of the quality of life. Supernumerary limbs will be partially controlled by artificial intelligence, and partially under the direct control of the human who gains the agency of some motion parameters of the supernumerary limbs. From the control point of view, it is fundamental to find the right trade-off between motion task parameters that are controlled by the user, and the level of robot autonomy. This interplay is enabled by the wearable sensorimotor interface that establishes a connection between the human sensorimotor system and the system of actuators and sensors of the robot, allowing reciprocal awareness, trustworthiness and mutual understanding. HARIA finds its natural application in assisting people with uni- or bi-lateral upper limbs chronic motor disabilities. Technology and methodology developments will follow a user-centered design approach, as only patients with disabilities are fully aware of their real (still unmet) needs in real life activities. This project will also go beyond the application to health, starting a new era of intuitive and seamless human-robot augmentation by wearable sensorimotor interfaces and supernumerary limbs.